Dr Reddy Laboratories Ltd

Most Recent

  • uploads///suboxone
    Company & Industry Overviews

    When Will Mylan Launch Its Recently Approved Generic Suboxone?

    Mylan (MYL) received FDA approval for its generic version of Indivior’s (INVVY) opioid addiction treatment drug, Suboxone, on June 14.

    By Sarah Collins
  • uploads///PRODUCTS AND PIPELINE
    Company & Industry Overviews

    A Look at Mylan’s Launch of Its Generic Angiomax Injection

    On June 1, Mylan (MYL) announced the launch of a generic version of the Medicines Company’s (MDCO) Angiomax, which is bivalirudin.

    By Sarah Collins
  • uploads/// outlook
    Company & Industry Overviews

    A Look at Teva Pharmaceutical’s Fiscal 2018 Sales Guidance

    Teva Pharmaceutical (TEVA) provided fiscal 2018 guidance during its fiscal 2017 earnings release on February 8, 2018.

    By Sarah Collins
  • uploads///Amitiza performance
    Company & Industry Overviews

    Sucampo Pharmaceuticals’ Amitiza: Its Performance in 2017

    Sucampo Pharmaceuticals has granted licenses to commercialize a generic or authorized generic of Amitiza in the United States to Par Pharmaceutical and Dr. Reddy’s Laboratories.

    By Kenneth Smith
  • uploads///Folotyn
    Company & Industry Overviews

    Spectrum Pharmaceuticals’ Product Licensing Agreements

    In 2012, Spectrum Pharmaceuticals (SPPI) acquired the rights to market Zevalin outside the US from Bayer for 19 million euros.

    By Kenneth Smith
  • uploads///Projections for India and ASEAN
    Macroeconomic Analysis

    IMF Economic Update: Still Upbeat on Some Emerging Economies

    Irrespective of how strong economic fundamentals look, investors should be careful about investing in emerging markets and other economies that are relatively unknown to them.

    By David Ashworth
  • uploads///Xgeva Revenue
    Company & Industry Overviews

    Xgeva Is Expected to See Robust Revenue Performance in 2017

    Amgen’s (AMGN) Xgeva was launched commercially in 2010 and is marketed primarily in the US and Europe. The drug crossed the $1 billion annual revenue mark in 2013.

    By Daniel Collins
  • uploads///Amgen Revenue
    Company & Industry Overviews

    What Could Drive Amgen’s Growth in 2017?

    Enbrel, Neulasta, and Epogen are among Amgen’s (AMGN) major revenue-generating drugs, each with annual sales in excess of $1 billion. Enbrel and Neulasta together accounted for ~46% of Amgen’s 2016 revenues.

    By Daniel Collins
  • uploads///MCLR of Some Indian Banks
    Macroeconomic Analysis

    Will Demonetization in India Impact Your Loan Burden?

    Banks saw a rise in term deposit accounts since the demonetization. As a result, commercial banks sharply reduced their deposit rates.

    By David Ashworth
  • uploads///MCLR of Some Indian Banks
    Macroeconomic Analysis

    Why the RBI Feels that Monetary Policy Transmission Can Improve in India

    Importance of policy transmission Monetary policy transmission refers to the translation of monetary policy actions into the financial system via banking and trading channels. By changing the short-term interest rate—like the repo rate in India or the federal funds rate in the US—a central bank signals other banks to change their lending and deposit rates. […]

    By David Ashworth
  • uploads///Equity Indices Reaction to RBI Announcement
    Company & Industry Overviews

    Indian Equities Rise after the RBI’s October 2016 Monetary Policy Announcement

    Equities gain Indian equities rose on October 4, 2016, the day of the RBI’s (Rerserve Bank of India) latest monetary policy announcement. The central bank’s cut of its repo rate had a positive effect on equities, with bonds rising initially along with the Indian rupee. Banking and telecom stocks were among major gainers during the […]

    By David Ashworth
  • uploads///Equity Indices Reaction to RBI Announcement
    Company & Industry Overviews

    Indian Equities and Funds Fall after the August Monetary Policy

    Indian equities fell on August 9, the day of the monetary policy announcement. Benchmark equity indices like the S&P BSE Sensex and the Nifty 50 fell 0.4%.

    By David Ashworth
  • uploads///Inflation and Policy Rates in Raghuram Rajans Term
    Macroeconomic Analysis

    Reviewing Raghuram Rajan’s Term as the RBI Governor

    Raghuram Rajan started his term as the 23rd governor of the RBI on September 5, 2013. He will be completing his three-year term this September.

    By David Ashworth
  • uploads///MCLR of Some Indian Banks
    Macroeconomic Analysis

    Efficient Policy Transmission in India Concerns the RBI

    “Policy transmission” refers to the translation of monetary policy actions into the financial system through the banking and trading channels.

    By David Ashworth
  • uploads///India to Drive Developing Asia
    Macroeconomic Analysis

    China Takes a Breather as India Drives Growth in Asia

    Even though the ADB (Asian Development Bank) slashed its economic growth projection for India for this year to 7.4%, the pace remains very healthy.

    By David Ashworth
  • uploads///Equity Indices Reaction to RBI Announcement
    Company & Industry Overviews

    How Did Indian Equities React to the RBI’s Repo Rate Cut in April 2016?

    Indian stock market indexes fell on April 5 when the Reserve Bank of India cut the repo rate by 25 basis points.

    By David Ashworth
  • uploads///Indian Economys Sectoral Breakup
    Macroeconomic Analysis

    How Have India’s Industry and Services Sectors Performed?

    In its monetary policy statement released on April 5, 2016, the RBI (Reserve Bank of India) said that the GVA (gross value added) by the industry sector “accelerated in H2” primarily due to low input costs.

    By David Ashworth
  • uploads///Returns of India Focused Funds
    Company & Industry Overviews

    Investing in Indian Stocks: Active versus Passive Modes

    The WisdomTree India Earnings ETF (EPI) is the most traded ETF that invests in Indian stocks. However, it is not the largest in terms of asset size.

    By David Ashworth
  • uploads///Performance of Indian Stock Indices
    Company & Industry Overviews

    Not a Good 1Q16 for Indian Stocks, but Is the Tide Turning?

    Indian stocks had a great March. The rebound began after the Union Budget announcement on February 29. The fiscal discipline shown by the government raised hopes that the Reserve Bank of India may reduce interest rates.

    By David Ashworth
  • uploads///Generic Pharma Sales
    Macroeconomic Analysis

    Expert Q&A: What to Know Before Investing in Generic Pharma? (Part 1)

    Market Realist analysts recently conducted a Q&A with experts from VanEck on the generic pharmaceutical industry, a space that has attracted investor interest due to upside potential from brand name drugs coming off patent, cost saving pressure in the healthcare industry, and increased worldwide demand for prescription drugs (for more on these topics, please see […]

    By VanEck
  • uploads///c
    Fund Managers

    How Does WAINX’s Performance Compare to Its Peers?

    In this part, we’ll compare WAINX to four similar India-focused funds. These include INDAX, MINDX, ETGIX, and FIGZX.

    By Pete Raine
  • uploads///c
    Fund Managers

    The Wasatch Emerging India Fund: A Look at a Fairly New Fund

    The Wasatch Emerging India Fund (WAINX) invests with the objective of long-term capital appreciation. The fund invests mainly in small-sized and mid-sized companies with a market cap less than $5 billion.

    By Pete Raine
  • uploads///c
    Fund Managers

    How Does the Matthews India Fund Compare to Its Peers?

    As of December 31, 2015, Matthews India Fund has the lowest holdings turnover among the five funds.

    By Pete Raine
  • uploads///c
    Fund Managers

    How MINDX’s Top Holdings Are Performing

    Healthcare was the best-performing sector in Indian markets in 2015.

    By Pete Raine
  • uploads///c
    Fund Managers

    How the Matthews India Fund Performed in Comparison to Benchmark

    The Matthews India Fund gave a negative return of -0.6% in 2015. However, it still managed to outperform its benchmark.

    By Pete Raine
  • uploads///c
    Fund Managers

    Understanding Matthews India Fund’s Investment Approach

    MINDX seeks to invest at least 80% of its total assets in publicly traded common stocks, preferred stocks, and convertible securities of companies located in India.

    By Pete Raine
  • uploads///p
    Company & Industry Overviews

    Looking ahead for Indian-Focused Funds

    All five India-focused funds have their highest individual sectoral exposure to financials. As reported in the news, 2015 has been a year of global economic stress.

    By Pete Raine
  • uploads///p
    Company & Industry Overviews

    The Wasatch Emerging India Fund Portfolio Composition

    As of December 2015, the Wasatch Emerging India Fund has ~$69.2 million in assets under management. As of September 30, 2015, the fund had 76 holdings in its portfolio.

    By Pete Raine
  • uploads///p
    Company & Industry Overviews

    How the Matthews India Fund and Its Holdings Performed in 2015

    In 2015, the Matthews India Fund returned -0.56%. It outperformed the benchmark index S&P BSE 100 over all the periods reviewed.

    By Pete Raine
  • uploads///p
    Company & Industry Overviews

    The Matthews India Fund Portfolio Analyzed

    The Matthews India Fund (MINDX) invests mainly in small-cap and mid-cap Indian stocks. As of November 2015, the fund had $1.5 billion in assets under management.

    By Pete Raine
  • uploads///Graph Kuvan
    Company & Industry Overviews

    What Are BioMarin’s Products for Treating Phenylketonuria?

    Kuvan, with the active ingredient sapropterin dihydrochloride, is effective in reducing blood phenylalanine levels in PKU (or phenylketonuria) patients.

    By Jillian Dabney
  • uploads///chart
    Company & Industry Overviews

    FPI in Indian Equities Remained Volatile in 2015

    After the first four months of an impressive net inflow of FPI, Indian equities lost a substantial investment of foreign money. August 2015 witnessed the highest exodus of foreign money from Indian equities.

    By Pete Raine
  • uploads///chart
    Macroeconomic Analysis

    A Sector-by-Sector Overview of India’s S&P Bombay Stock Exchange

    The S&P BSE sector indexes are Energy, Finance, Industrials, Telecom, Utilities, Information Technology, and Healthcare.

    By Pete Raine
  • uploads///Food Articles Inflation in India
    Macroeconomic Analysis

    The Projected Path of Consumer Price Index Inflation in India

    According to the RBI, consumer price index inflation is expected to begin rising in September 2015 and continue rising for a few months.

    By David Ashworth
  • uploads///usdinr aug
    Macroeconomic Analysis

    The Nikkei India Manufacturing PMI Rises to a Half-Year High

    The Nikkei India manufacturing PMI for the manufacturing sector improved to a six-month high of 52.7 in July compared to 51.3 in June.

    By David Meyer
  • uploads///Article
    Company & Industry Overviews

    Nutritionals: Abbott Laboratories’ Main Segment

    Abbott Laboratories’ (ABT) nutritional products segment includes a broad line of pediatric and adult nutritional products manufactured and marketed worldwide.

    By Mike Benson
  • uploads///INDA adjusted close price
    Macroeconomic Analysis

    The Booming Indian Stock Market: Will It Last?

    Indian stocks had a strong run in the last half of 2014 through early 2015, but the ride since then hasn’t been smooth. The INDA is up only 2.6% in the one year ended June 2015.

    By David Ashworth
  • uploads///Investors
    Macroeconomic Analysis

    What Lies Ahead for the Modi Government?

    Attracting foreign investment has been key for the Modi government in its first year, particularly given all those visits abroad. This is a step in the right direction.

    By David Ashworth
  • uploads///Net Foreign Direct Investment into India
    Macroeconomic Analysis

    Foreign Direct Investment in India Up 61% since Last Year

    It appears that Modi’s trips abroad are working, and that his schemes and plans have attracted foreign direct investment into the country.

    By David Ashworth
  • uploads///Part __Oil Prices and BSE
    Fund Managers

    India’s Foreign Investors Upset about Minimum Alternate Tax Rules

    Indian markets have experienced a massive drain of foreign funds since April, mostly fueled by uncertainty over the minimum alternate tax rules.

    By Stuart McKenzie
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.